We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,704
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VST.WS.A
6751
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
$18K ﹤0.01%
+14,189
New +$12.9K
ONCT
6752
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$18K ﹤0.01%
8
+3
+60% +$7.61K
BNFT
6753
DELISTED
Benefitfocus, Inc.
BNFT
$18K ﹤0.01%
538
-7,566
-93% -$237K
ICBK
6754
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$18K ﹤0.01%
651
+23
+4% +$645
OLD
6755
DELISTED
The Long-Term Care ETF
OLD
$18K ﹤0.01%
727
-884
-55% -$21K
STND
6756
DELISTED
Standard AVB Financial Corp. Common Stock
STND
$18K ﹤0.01%
+600
New +$18.4K
MR
6757
DELISTED
Montage Resources Corporation Common Stock
MR
$18K ﹤0.01%
+750
New +$16.8K
SDI
6758
DELISTED
Standard Diversified Inc. Class A Common Stock
SDI
$18K ﹤0.01%
+1,220
New +$15.2K
HYACU
6759
DELISTED
Haymaker Acquisition Corp. Unit
HYACU
$18K ﹤0.01%
1,802
-4,245
-70% -$42.8K
XRM
6760
DELISTED
Xerium Technologies Inc (new)
XRM
$18K ﹤0.01%
1,374
-1,849
-57% -$13.3K
HEUV
6761
DELISTED
iShares Edge MSCI Min Vol Europe Currency Hedged ETF
HEUV
$18K ﹤0.01%
700
VMAX
6762
DELISTED
REX VolMAXX Long VIX Futures Strategy ETF
VMAX
$18K ﹤0.01%
876
+531
+154% +$11.1K
FUT
6763
DELISTED
ProShares Managed Futures Strategy ETF
FUT
$18K ﹤0.01%
461
+62
+16% +$2.46K
LEXEB
6764
DELISTED
Liberty Expedia Holdings, Inc. Class B Common Stock
LEXEB
$18K ﹤0.01%
422
-119
-22% -$5.02K
AGF
6765
DELISTED
DB Agriculture Long ETN due April 1, 2038
AGF
$18K ﹤0.01%
1,955
-700
-26% -$7.06K
YDKG
6766
Yueda Digital Holding
YDKG
$5.92M
$17K ﹤0.01%
+13
New +$18.3K
APYX icon
6767
Apyx Medical
APYX
$180M
$17K ﹤0.01%
4,000
-284
-7% -$1.05K
BH.A icon
6768
Biglari Holdings Class A
BH.A
$1.23B
$17K ﹤0.01%
+18
New +$18K
CPIX icon
6769
Cumberland Pharmaceuticals
CPIX
$116M
$17K ﹤0.01%
2,822
+1,393
+97% +$8.71K
OPPJ
6770
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$279M
$17K ﹤0.01%
768
-3,808
-83% -$86.2K
GBR icon
6771
New Concept Energy
GBR
$3.46M
$17K ﹤0.01%
3,938
-2,470
-39% -$3.52K
HDMV icon
6772
First Trust Horizon Managed Volatility Developed International ETF
HDMV
$17.6M
$17K ﹤0.01%
507
+332
+190% +$11.4K
HL.PRB icon
6773
Hecla Mining Co Series B Preferred Stock
HL.PRB
$10.4M
$17K ﹤0.01%
331
-8
-2% -$435
III icon
6774
Information Services Group
III
$210M
$17K ﹤0.01%
+4,260
New +$17.7K
MBIO icon
6775
Mustang Bio
MBIO
$4.5M
$17K ﹤0.01%
3
+1
+50% +$6.32K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,704 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.